Synthesis of 4,5-dichloro-1-(4,5-dichloropyridazin-3-yl)pyridazin-6-one

DOI: 10.1002/jhet.5570360531

Source and publish data:

Journal of Heterocyclic Chemistry p. 1301 - 1306 (1999)

Update date:2022-08-04

Topics:

Authors:

Kweon, Deok-Heon

Kang, Young-Jin

Chung, Hyun-A.

Park, Jung-Won

Lee, Woo Song

Yoon, Yong-Jin

Kim, Sung-Kyu

Shiro, Motoo

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jhet.5570360531

This paper presents the synthesis of 4,5-dichloro-1-(4,5- dichloropyridazin-3-yl)pyridazin-6-one from 4,5-dichloropyridazin-6-one.

Full text of DOI:10.1002/jhet.5570360531

Products guided by the article

Product name:4,4',5,5'-Tetrachloro-[1(6H),3'-bipyridazin]-6-one

Cas No:258340-49-7

R&D Labs maybe for 258340-49-7

Lanzhou huibang biological chemical technology Co., LTD

Contact:0931-7843964

Address:NO.2011,Yannan Road,Chengguan,
LIDE PHARMACEUTICALS LIMITED

website:http://www.lidepharma.com

Contact:+86-25-58409506

Address:11F, Building A1, No.288 North Zhongshan Road, Gulou District, Nanjing,210003, P.R.China.
Forsman Scientific(Beijing)co.,Ltd.

Contact:+86-10-64646565

Address:Rm No.1301, Building-2, No. A-13 Beiyuan Road, Chaoyang District Beijing, China, PR,
Beijing Stable Chemcial Co.ltd

Contact:86-10-63785052

Address:A1301 Technological Edifice. No.4 FuFeng Road,FengTai District, Beijing. China
NanJing Rate Biochemicals CO., LTD

Contact:+86-25-84931986

Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China

Relevant to this article

Synthesis and anti-HIV activity of 1,3,4,5-tetrahydro-2H-1,4- benzodiazepin-2-one (TBO) derivatives. Truncated 4,5,6,7-tetrahydro-5- methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (TIBO) analogues

Doi:10.1016/S0968-0896(99)00198-4
(1999)
Synthesis of a new chiral polyamine template - Towards an active site analogue of vanadium haloperoxidase

Doi:10.1055/s-1999-2969
(1999)
Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor.

Doi:10.1016/S0968-0896(02)00009-3
(2002)
Asymmetric synthesis of (+)-dihydrokawain-5-ol

Doi:10.1021/jo991307n
(2000)
Use of readily available chiral compounds related to the Betti base in the enantioselective addition of diethylzinc to aryl aldehydes

Doi:10.1016/S0040-4020(99)00914-X
(1999)
Ring closure strategy leads to potent RIPK3 inhibitors

Doi:10.1016/j.ejmech.2021.113327
(2021)

Article Doi